US appeals court revives lawsuits linking Tylenol use during pregnancy to autism and ADHD
The 2nd U.S. Circuit Court of Appeals revived more than 500 private lawsuits against Kenvue, maker of Tylenol, on July 13, 2026. The court ruled that a district court judge improperly excluded expert testimony from three doctors who linked acetaminophen use during pregnancy to autism and ADHD. The decision returns the cases to U.S. District Judge Denise Cote for further proceedings.
11
Divergence score
3 outlets covered it, splitting into 3 framing camps across 2 bias groups.
3 camps
2 bias groups
Market signalBETA
The spectrum · how 3 outlets placed this story
LeftCenterRight
Globe and Mail
The Hill
Reuters
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
All three outlets report the same ruling with consistent facts; Globe and Mail adds stock price movements and the Kimberly-Clark acquisition context, while The Hill and Reuters provide only core legal findings.
How each outlet covered it
No left-right split here
Coverage clusters in the center and international press. Here is each take as it stands.
Center & international coverage
“U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims”
“Appeals court revives lawsuits claiming link between acetaminophen, ADHD and autism”
“US appeals court revives private lawsuits linking Tylenol to autism, ADHD”
Tracked claims from across the political spectrum
Fact ledger
Corroborated
Disputed